Proton Pump Inhibitors Market is Estimated to Witness High Growth Owing to Rising Geriatric Population

Proton Pump Inhibitors Market

 Proton Pump Inhibitors are a type of medications that work by reducing the amount of acid produced in the stomach. They are commonly used for treating gastric and duodenal ulcers, gastroesophageal reflux disease and other conditions caused by excessive stomach acid. These medications provide effective relief from symptoms such as heartburn and acid regurgitation. With rising geriatric population worldwide, the incidence of acid-related disorders has increased at an alarming rate. According to estimates, over 60 million Americans experience acid reflux symptoms every year.


The global Proton Pump Inhibitors Market is estimated to be valued at US$ 3.8 Mn in 2023 and is expected to exhibit a CAGR of 6.7% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.

Market Opportunity:

The rising geriatric population presents a massive market opportunity for Proton Pump Inhibitors. Older adults are more prone to acid-related disorders due to a decline in digestive functions with age. According to the United Nations, the population aged 60 years and above is expected to double from 12% to 22% between 2015 and 2050. As per a Harvard study, over 60% of Americans aged 65 and above experience symptoms of acid reflux at least once a month. With the aging demographic trend worldwide, the need for drugs that provide relief from excessive stomach acid is projected to increase substantially. This represents a huge opportunity for manufacturers to develop effective and safe PPI drugs targeted towards the elderly population.

Porter's Analysis

Threat of new entrants: Low as this is a mature market dominated by large pharmaceutical players who have patent protection on popular drugs. New players require large investment in R&D.

Bargaining power of buyers: Moderate to high as major buyers include large pharmacy chains and hospitals that can negotiate on price and demand new product launches.

Bargaining power of suppliers: Moderate as key raw materials and active pharmaceutical ingredients have alternatives however changing suppliers requires regulatory approvals.

Threat of new substitutes: Moderate threat from newly launched drugs or those in pipeline targeting acid reflux disease however PPIs remain gold standard.

Competitive rivalry: High among leading players to gain market share and expand indications through continuous innovations.

SWOT Analysis

Strengths: Established brands, clinical effectiveness at relieving symptoms, widespread insurance coverage and strong distribution networks.

Weaknesses: Concerns around long term safety risks such as bone fractures and magnesium deficiency, rising generic competition eroding prices of major drugs.

Opportunities: Expanding indications to new disease areas, emerging markets witnessing rise in acid reflux cases, combinations with other drugs.

Threats: Safety alerts reducing prescription rates, disruptive technologies offering non-drug alternatives, unfavorable drug price control policies.

Key Takeaways

The Global Proton Pump Inhibitors Market Share is expected to witness high growth over the forecast period driven by increasing instances of acid reflux disease and preference for pharmaceutical treatment options. The global Proton Pump Inhibitors Market is estimated to be valued at US$ 3.8 Mn in 2023 and is expected to exhibit a CAGR of 6.7% over the forecast period 2024 to 2031.

Regional analysis indicates North America currently dominates due to well-established healthcare systems and higher diagnosis rates while Asia Pacific is poised to be the fastest growing market supported by economic growth, rising medical expenditures and shift towards western lifestyle in many countries.

Key players operating in the Proton Pump Inhibitors market are Horizon Therapeutics plc, Ammonett Pharma LLC, Medison Pharma Ltd., Modern Dietetics Inc., Synageva BioPharma Corp., Medison Pharma Ltd., Swedish Orphan Biovitrum AB (Sobi), Entera Health, Inc., Dipharma Francis S.r.l., Ucyclyd Pharma, Inc. Horizon Therapeutics holds a leading share through its popular brand Dexilant while Ammonett and Medison Pharma enjoy strong positions in the generic drug space.

For more insights, Read- https://www.trendingwebwire.com/proton-pump-inhibitors-market-growth-demand-and-overview/

Comments

Post a Comment

Popular posts from this blog

The Notchback Market is Estimated To Witness High Growth Owing To Rising Demand From Emerging Economies

Image
  Notchback Market Market Overview: A notchback is a body style of cars characterized by a gently sloped rear window and greenhouse. Notchbacks provide practical interior space with good cargo capacity. They offer balanced interior volume for passengers and cargo along with sleek and stylish exterior design. The body style has advantages like no C-pillar which enhances visibility compared to sedans. Market key trends: The growth of the notchback market is attributed to rising demand from emerging economies like China, India and Brazil. These nations have growing middle-class population and increasing disposable income which is driving vehicle ownership. Moreover, notchback body style is quite popular in these developing markets due to its spacious cabin combined with stylish looks at affordable prices. Leading automakers are launching various notchback models to cater to the surging demand from developing countries, which is fueling the growth of the notchback market size during ...
Read more

Commercial Drones Market is Poised to Register Notable Growth Owing to Expanding Usage Across Varied Industries

Image
  Commercial Drones Market  The commercial drones market has been gaining significant traction over the recent years primarily driven by expanding deployment across various industries including agriculture, infrastructure, disaster management, and transportation among others. Commercial drones offer several advantages including cost-effectiveness, flexibility, precision and real-time monitoring capabilities. Meanwhile, growing popularity of drone delivery services across e-commerce as well as healthcare sectors has further catalyzed the market growth. Drones help in reducing operational costs while effectively meeting the target delivery timelines. Additionally, continuous technological advancements have resulted in miniaturization and development of drones with increased payload capacity and battery life. The Global commercial drones market is estimated to be valued at US$ 22.29 Bn in 2024 and is expected to exhibit a CAGR of 13% over the forecast period 2024 to 2031. Key T...
Read more

The increasing demand for adhesives and sealants is anticipated to open up the new avenue for Petroleum Resins Market

Image
Petroleum Resins Market  Market Overview: Petroleum resins are amorphous thermoplastic polymers made from petroleum-based feedstock materials, through either thermal or catalytic polymerization. They are mainly used for applications such as adhesives, inks, paints, rubber compounding, and others. Different types of petroleum resins include C5 resins, C9 resins, hydrogenated hydrocarbons (HHCs), and modified and specialized petroleum resins. Among applications, adhesives and sealants hold the largest share in the petroleum resins market owing to increasing use of petroleum resins in hot melt and pressure sensitive adhesives. Market Dynamics: The increasing demand for adhesives from packaging and construction industries is a major driver for the petroleum resins market. According to statsista, the global adhesive market was valued at over US$ 53.3 billion in 2020 and is projected to reach around US$ 78 billion by 2027, growing at a CAGR of over 5.7% during the forecast period. Pe...
Read more